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Abstract
Background: Folic acid may affect the development of human cancers. However, few studies have evaluated the
consumption of diet folate in the prognosis of patients with esophageal squamous cell carcinoma (ESCC).
Methods: One hundred and twenty five ESCC patients underwent esophagectomy between January 2005 and
March 2006 in the Yangzhong People’s Hospital were recruited and followed up. The effects of diet folate, aberrant
DNA methylation of selected genes and methylenetetrahydrofolate reductase (MTHFR) C677T genetic
polymorphisms on the prognosis of ESCC were evaluated by using Cox proportional hazard regression models.
Results: Our analysis showed an inverse association between diet folate intake and the risk of death after
esophagectomy. The median survival time was 3.06 years for low or moderate folate consumption and over 4.59
years for high folate consumption. After adjusting for potential confounders, the hazard ratios (95% confidence
interval) [HRs (95% CI)] were 0.72 (0.36-1.46) for moderate and 0.39 (0.20-0.78) for high folate intake, respectively (P
for trend = 0.007). This preventive effect was more evident in patients carrying MTHFR 677CC genotype. No
significant relation was observed between aberrant DNA methylation of P16, MGMT and hMLH1 gene, as well as
MTHFR C677T genetic polymorphisms and the prognosis of ESCC.
Conclusions: Our research indicated that diet folate intake may have benefits on the prognosis of ESCC after
esophagectomy. From a practical viewpoint, the findings of our study help to establish practical intervention and
surveillance strategies for managements of ESCC patients and can finally decrease the disease burden.
Background
Esophageal cancer has been ranked as one of the most
common cause of death from cancers worldwide [1]. In
contrast with the esophageal adenocarcinoma arising
from Barrett’s esophagus in western countries, the
major phenotype in the Asia-Pacific region is esophageal
squamous cell carcinoma (ESCC) [2,3]. Possible risk fac-
tors for ESCC include cigarette smoking, alcohol drink-
ing, hot-temperature food items, chronic mucosal
irritation, and a family history of cancers [4-6]. Defi-
ciency of nutrients, such as vitamins and micro-
elements, was also found to be associated with an
increased risk for ESCC, whereas a high intake of fruits
and vegetables has been considered to be effective in
prevention [5].
Folate is a water-soluble vitamin and naturally found
in green leafy vegetables, cereals, legumes and fruits [7].
Folate is necessary for de novo synthesis of thymine,
which is important in DNA synthesis, integrity and sta-
bility [8,9]. Deficiency of folate may cause defective
DNA repair and chromosomal fragile site expression,
leading to chromosomal breaks and micronucleus for-
mation [7]. Furthermore, folate is the primary methyl
group donor which has a central role in DNA methyla-
tion [8-10]. More and more evidence has indicated the
association of folate, as well as the aberrant DNA
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However, the role of dietary folate in cancers is still
controversial and the studies on the relation between
folate intake and ESCC in Chinese population were
scarce till now. Only several studies reported that diet-
ary folate was negatively associated with the risk of
endometrial cancer [13], breast cancer [14] and rectal
cancer [15]. High folate intake has been found to be sig-
nificantly related with better survival of patients with
advanced gastric cancer who were treated with first-line
fluorouracil-based chemotherapy [16]. Considering the
folate pool imbalance and impaired repair mechanisms
may result in DNA instability and strand breaks, we
hypothesized that folate insufficiency disrupts global and
specific gene methylation patterns may not only influ-
ence the susceptibility to, but also the progression of
ESCC. Hence, we conducted an epidemiological study
based on an esophageal cancer patient’s cohort in a
Chinese population.
Methods
Study subjects
The procedures for case recruitment were described
previously [17]. Briefly, 125 ESCC patients underwent
esophagectomy between January 2005 and March 2006
in the Yangzhong People’s Hospital were involved in
this study, which accounted for about more than 80% of
cases under esophageal cancer surgery in this hospital
during the same period. The eligible cases were Han
Chinese living in Yangzhong for more than five years,
with pathologically confirmed ESCC and informed con-
sent. The recrudesced cancer patients or cases with the
secondary ESCC from a primary cancer located else-
where were excluded. Yangzhong is an island county on
the middle of Yangtze River in southeast part of Jiangsu
Province of China and is well known for the high mor-
tality and incidence of the stomach and esophageal
cancer [3]. No programs of government-mandated folate
fortification of processed foods have been performed in
the study site. All recruited patients were followed by
professional staff of Yangzhong Cancer Research Insti-
tute by the end of September, 2009.
Data collection
After obtaining written informed consent from all partici-
pants, trained interviewers administered the risk factor
questionnaire to collect information on socio-demographic
factors, tobacco smoking, alcohol drinking, and dietary
habits. The food frequency questionnaire (FFQ) was used
to estimate the usual dietary intake. The FFQ used in the
present study was referred by NIH (National Institutes of
Health, USA) and modified according to Chinese food
items and cooking habits. For each food item, we collected
the frequency and quantity of consumption, and then
calculated daily intake by multiplying the frequency
reported for the consumption of each food item by the
specified portion size. Dietary intake of folate during the
last 1-2 years prior to diagnosis was ascertained. Peripheral
blood was collected with vacuum blood tubes. For those
patients underwent surgery, tissues in the center of the
cancer lesion and remote normal appearing esophagus
were excised and stored in -70°C refrigerator immediately.
In this study, we defined never smokers as individuals
who had smoked less than100 cigarettes totally during
their lifetime, and former smokers as individuals who
had stopped smoking for at least 1 year at the time of
diagnosis.
Experiments
DNA was extracted by proteinase K digestion and a
modified phenol-chloroform protocol. The CpG island
methylation at the promoter region of P16, MGMT and
hMLH1 was determined by methylation specific PCR
(MSP) after sodium bisulfite modification of DNA
[17,18]. In brief, genomic DNA was incubated with
NaOH at 37°C for 10 minutes and then treated with
freshly prepared hydroquinone and NaHSO3. Samples
were incubated under mineral oil at 50°C for 16 hours.
Modified DNA was purified and eluted with 50ul pre-
heated TE solution. Modification was completed by the
treatment of 5.5ul 3 M NaOH (final concentration
0.3 M) for 15-20 minutes at room temperature. DNA
was precipitated by ethanol and resolved in TE. The
CpG island methylation at the promoter region of P16,
MGMT and hMLH1 genes was assessed by MSP using
methylation-specific primer and relevant annealing tem-
perature [17]. A methylation positive DNA control sam-
ple was made in vitro by SssI methylase (New England
Biolabs). PCR products were loaded onto 3% gels,
stained with ethidium bromide, and directly visualized
under UV illumination. Methylenetetrahydrofolate
reductase (MTHFR) C677T genetic polymorphism
(rs1801133) was detected by Polymerase Chain Reac-
tion-Restriction Fragment Length Polymorphism (PCR-
RFLP). The forward primer was ‘T G AA G GA G AA G G
TGT CTG CGG GA’ and the backward primer was
‘A G GA C GG T GC G GT G AG A GT G ’. PCR products
were digested overnight at 37°C with restriction endonu-
clease HinfI and then the digestive products were
resolved on 3% agarose gel and visualized under UV
light after staining with ethidium bromide. The variant
genotype TT has two bands (175bp and 23bp). The het-
erozygote CT has three bands (198bp, 175bp and 23bp)
while the wild genotype CC has only one 198 bp band.
Statistical analyses
Statistical analyses were performed by using STATA
10.0 (College Station, TX, USA). Cox proportional
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lating hazard ratios (HRs) and the 95% confidence inter-
vals (95% CIs). The primary death of esophageal cancer
was defined as the failure event and the time of survival
was the time between diagnosis and death. The cause of
death was defined by specialists based on the clinical
documents and reports by patient’s family members. If
the patient died of other causes rather than esophageal
cancer, he/she was censored at the date of death. All
survived patients were censored at the date of last fol-
low-up. The diet folate intake for each food item was
calculated by multiplying the weight (grams) of food
intake and the folate content (per gram) referring to a
national food nutrition database [19,20]. And then the
sum of folate took from various foods was calculated as
the total folate intake. In this study, we used the folate
from fresh fruits as a representative value for the total
dietary folate intake. The continuous variables of folate
intake were transferred to three categories as low, mod-
erate, and high by using tertile as the cut point. Dummy
variables were used to estimate HRs for categorical vari-
ables of exposure. The differences between distinct diet
folate intake categories were compared by using the
Kaplan-Meier curves and Log-rank test. All tests were
two-sided with a significant level of P < 0.05 based.
Ethics consideration
This project has been approved by the IRB of the School
of Public Health, Fudan University, China (IRB#05-06-
0031). Ethics has been respected throughout the whole
study period.
Results
Briefly, 125 ESCC patients underwent esophagectomy
between January 2005 and March 2006 in the Yangz-
hong People’s Hospital were recruited in this study. All
patients had operation within 2 weeks after diagnosis.
The majority of the patients were males (64.8%) and the
average age (mean ± SD) was 61.8 ± 7.0 years. Patients
were followed up since the diagnosis until the end of
September, 2009. Among the 125 ESCC patients, 5 were
lost to follow-up due to migration. Finally, 120 patients
were investigated successfully. The median time of fol-
low-up was 3.5 years (minimum and maximum were
0.03 and 4.66 years, respectively). Fifty-eight out of them
(48.33%) died of esophageal cancer during the follow-up
period.
As shown in Table 1 no significant association was
found between the prognosis of ESCC and selected
demographic characteristics such as sex, age, tobacco
smoking, alcohol drinking, and education level. The
patients divorced or living alone had a borderline signifi-
cantly increased risk of death (HR: 1.96, 95% CI: 0.99-
3.88). The association between clinical characteristics
and the prognosis of ESCC were shown in Table 2. Both
TN and clinical stages were related to the survival time
and the trend was significant too. Compared with
patients at T1 stage, subjects at T2, T3 and T4 stage
had elevated risks of death with the HR(95% CI) of 1.52
(0.55-4.20), 3.80(1.47-9.79) and 7.65(2.4-24.32), respec-
tively. We further explored the role of aberrant DNA
methylation of P16, MGMT and hMLH1 genes, as well
as MTHFR C677T genetic polymorphisms in the prog-
nosis of ESCC, but no significant association was
observed (Table 3). However, we found an inverse rela-
tion between diet folate intake and the risk of death. As
shown in Figure 1 the median survival time were
3.06 years for low or moderate and more than 4.59
years for high folate consumption (log-rank test P =
0.063). After adjusting for potential confounders (age,
sex, T stage and N stage), the HRs (95% CI) were 0.72
(0.36-1.46) and 0.39(0.20-0.78) for moderate and high
folate intake, respectively (P for trend = 0.007). After
stratified by MTHFR C677T genotypes, the preventive
effects were shown in patients carrying MTHFR 677CC
genotype with high dose of folate intake (Table 4).
Discussion
The present study indicated that ESCC patients with
high folate consumption may have better survival after
Table 1 Association between demographic characteristics
and the prognosis of ESCC
Characteristics Total
patients
Death, N
(%)
HR(95% CI)
† P
Sex
Male 79 38(48.10) 1
Female 41 20(48.78) 1.04(0.60-1.78) 0.895
Age(years)
< 63 61 27(44.26) 1
≥63 59 31(52.54) 1.30(0.78-2.18) 0.320
Tobacco smoking
Never 65 31(47.69) 1
Ever 55 27(49.09) 1.02(0.61-1.70) 0.947
Alcohol drinking
Never 69 33(47.83) 1
Ever 51 25(49.02) 1.02(0.61-1.72) 0.927
Marriage
Married 106 48(45.28) 1
Divorced/living
alone
14 10(71.43) 1.96(0.99-3.88) 0.054
Education
Illiterate 40 20(50.00) 1
< 6 years 46 22(47.83) 0.91(0.50-1.67) 0.759
≥6 years 34 16(47.06) 0.89(0.46-1.71) 0.719
P for trend 0.714
†: HR(95% CI), hazard ratio (95% confidence interval).
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protective effect was more evident in patients carrying
MTHFR 677CC genotypes. Mechanistically, this may
make sense taking into account the putative effect of
folate metabolism in the development and prognosis of
human cancers.
Folate mediates the transfer of one-carbon moieties
both in the synthesis of nucleotides necessary for DNA
synthesis, replication, and repair and in DNA methyla-
tion reactions [17]. These functions may play a critical
role in carcinogenesis. Evidence indicates that an abun-
dant intake of food stuffs rich in folate conveys protec-
tion against the development of some common cancers
[21]. Although various epidemiological studies have
shown the inverse association between folate intake and
the risk of cancers, the role of folate supplement for
specific population in the carcinogenesis is still contro-
versial [9]. In some animal studies, dietary folate
deficiency can inhibit rather than enhance the develop-
ment of breast cancer [22,23], which is in contrast to
the observation in epidemiological studies. Some even
demonstrate that an overly abundant intake of folate
might instead produce a paradoxical promotion of
tumorigenesis among those who harbour pre-existing,
undiagnosed precancerous and cancer lesions [7,21].
Mason et al. reported a temporal association between
folic acid fortification of enriched cereal grains and an
increase in the incidence of colorectal cancer in the
United States and Canada [24]. It has been accepted
that folate possesses dual effects on carcinogenesis
depending on the time and dose of intake. High con-
sumption of folate might be a risk fact for pre-existing
and cancer lesions, but could also be benefit for patients
after tumour being removed.
Table 2 Association between clinical characteristics and
the prognosis of ESCC
Characteristics Total
patients
Death, N
(%)
HR(95% CI)
† P
Site
Upper 23 13(56.52) 1
Middle 64 30(46.88) 0.80(0.42-1.54) 0.507
Low 33 15(45.45) 0.74(0.35-1.55) 0.424
TNM stage
T
1 21 5(23.81) 1
2 44 15(34.09) 1.52(0.55-4.20) 0.414
3 47 31(65.96) 3.80(1.47-9.79) 0.006
4 8 7(87.50) 7.65(2.40-
24.32)
0.001
P for trend <
0.001
N
0 62 18(29.03) 1
1 58 40(68.97) 3.54(2.02-6.19) <
0.001
M
0 119 58(48.74) 1
1 1 0(0) - -
Clinical stage
1/2 61 20(32.79) 1
3/4 59 38(64.41) 2.83(1.64-4.87) <
0.001
Chemo-therapy
No 114 57(50.00) 1
Yes 6 1(16.67) 0.25(0.03-1.79) 0.167
Radio-therapy
No 91 41(45.05) 1
Yes 28 17(60.71) 1.45(0.83-2.56) 0.195
†: HR(95% CI), hazard ratio (95% confidence interval).
Table 3 Association between aberrant DNA methylation
and the prognosis of ESCC
Characteristics Total
patients
Death, N
(%)
HR(95% CI)
† P
Cancer tissue
P16
Unmethylated 14 8(57.14) 1
Methylated 106 50(47.17) 0.67(0.32-1.41) 0.288
MGMT
Unmethylated 88 43(48.86) 1
Methylated 32 15(46.88) 1.00(0.55-1.79) 0.989
hMLH1
Unmethylated 116 56(48.28) 1
Methylated 4 2(50.00) 1.16(0.28-4.76) 0.836
Any gene
Unmethylated 11 5(45.45) 1
Methylated 109 53(48.62) 1.07(0.43-2.69) 0.880
Remote normal appearing tissue
P16
Unmethylated 74 36(48.65) 1
Methylated 46 22(47.83) 1.02(0.60-1.74) 0.937
MGMT
Unmethylated 107 51(47.66) 1
Methylated 13 7(53.85) 1.35(0.61-2.97) 0.461
hMLH1
Unmethylated 120 58(48.33) - -
Methylated 0 - - -
Any gene
Unmethylated 67 32(47.76) 1
Methylated 53 26(49.06) 1.13(0.67-1.89) 0.655
MTHFR C677T
CC 35 16(45.71) 1
CT 54 28(51.85) 1.15(0.62-2.13) 0.653
TT 31 14(45.16) 0.98(0.48-2.02) 0.964
CT+TT 85 42(49.41) 1.09(0.61-1.94) 0.770
†: HR(95% CI), hazard ratio (95% confidence interval).
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abundance is the risk of modification on DNA methyla-
tion [9]. Aberrant methylation occurring in cancers
includes global hypomethylation in genomic DNA as
well as hypermethylation in specific gene promoters
[25]. Loss of global DNA methylation may induce
genomic instability and thereby promote carcinogenesis
whereas promoter hypermethylation usually results in
transcriptional gene inactivation [26]. In our previous
study, we have reported that the aberrant CpG island
hypermethylation of cancer related genes was associated
with the clinical characteristics of ESCC and might be a
Figure 1 Kaplan-Meier survival estimates for patients in the prognosis of esophageal squamous cell carcinoma. MST: median survival
time.
Table 4 Diet folate intake and MTHFR C677T polymorphism in the prognosis of ESCC
MTHFR C677T Folate intake
† Total patients Death, N(%) aHR(95% CI)* P
Overall Low 39 22(56.41) 1
Moderate 38 19(50.00) 0.72(0.36-1.46) 0.366
High 38 14(36.84) 0.39(0.20-0.78) 0.007
P for trend 0.007
CC Low 12 7(58.33) 1
Moderate 12 6(50.00) 0.33(0.07-1.50) 0.152
High 11 3(27.27) 0.14(0.03-0.76) 0.023
P for trend 0.025
CT Low 19 13(68.42) 1
Moderate 13 5(38.46) 0.62(0.18-2.09) 0.441
High 19 8(42.11) 0.42(0.17-1.01) 0.054
P for trend 0.053
TT Low 8 2(25.00) 1
Moderate 13 8(61.54) 1.46(0.22-9.68) 0.696
High 8 3(37.50) 0.88(0.09-8.74) 0.914
P for trend 0.921
† The cut point of folate intake is tertile (μg/d). Low: <30.0; moderate: 30.0-95.4; high: ≥95.5.
*: aHR(95% CI), adjusted hazard ratio (95% confidence interval); adjusted for age, sex, T stage and N stage.
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until now few studies have been conducted to explore
the role of folate and DNA methylation in association
with the prognosis of ESCC after surgery. In the present
study, we didn’t observe a significant association
between the methylation of selected genes and the survi-
val of patients with ESCC. It might due to the limited
biomarkers we have tested and the small sample size of
patients we have recruited. Another explanation was
that we only tested the methylation status before surgery
and patients would have changed life styles after
esophagectomy.
In addition, the activity of folate metabolic enzymes,
such as MTHFR, methionine synthase (MTR) and thy-
midylate synthase (TS) are also involved in the folate
metabolic and DNA methylation process. As a key
enzyme in folate metabolism, the product of MTHFR
serves as the carbon donor for the methylation of
homocysteine tomethionine, which is catalyzed by
the enzyme MTR [27]. The MTHFR gene is highly poly-
morphic in the general population, with the most
common functional variant of 677 C to T. This poly-
morphism results in an alanine to valine substitution,
leading to a reduction in enzyme activity [28]. A pooled
analysis including 725 cases and 1531 controls showed a
significant association between the MTHFR 677 TT gen-
otype and susceptibility to esophageal cancer [28], but
its effect in the prognosis of cancer patients is unclear.
In the present study, we did not observe a significant
independent effect of the MTHFR C677T polymorphism
on patient’s survival, which was consistent to the report
by Sarbia [27]. It might due to the large variety of other
factors than genetic polymorphisms which may influ-
ence the activity of the key enzymes involved in folate
metabolism. For example, a study examined the folate
status and MTHFR C677T polymorphism on genomic
DNA methylation in peripheral blood mononuclear cell
and found that the MTHFR C677T polymorphism could
influence DNA methylation status through an interac-
tion with folate status [29]. Interestingly, we found that
diet folate intake had different effects on the prognosis
of ESCC by different genotypes of MTHFR C677T. The
preventive effect of folate intake was more evident in
patients carrying MTHFR 677CC genotype. This finding
indicates that ESCC prognosis might be influenced by
folate intake in relation to MTHFR C677T genotypes.
There are some limitations of this study. First, data on
baseline diet were collected at enrolment, asking about
consumption in the last 1-2 years prior to participants’
cancer diagnosis. Studies of ESCC prognosis that rely on
prediagnostic exposure information might result in sub-
stantial misclassification as patients may change life
styles after diagnosis. Second, FFQ has been widely used
to measure dietary folate and has been proved to be
valid and economic in western countries. However, as
the diet habits are significantly different between China
and western countries, the application of FFQ in Chi-
nese population is facing some difficulties. (1) The
recipe in China is very complex compared to that in
western countries. So it is difficult to recall and calculate
the type and amount of each food item. (2) As we know,
the main sources of dietary folate are fruits, vegetables,
legumes, cereals, and liver [8]. The folate is susceptible
to heat, pH, and oxidation. Incorrect cooking methods
would influence the actual intake of folate. Estimated
folate intake from total consumed food using FFQ may
not accurately reflect the true intake of total dietary
folate [8]. According to the traditional habits in Yangz-
hong County, people like to fry vegetables under higher
temperature or boil it for a long time which will destroy
the folate easily. It might not be appropriate to calculate
folate intake by summarizing all consumed food. So, in
this study, we try to use folate from fresh fruits for the
indicator of total dietary folate intake. Some evidences
from other studies also support it. For example, Flood
[30] reported that there existed a significant correlation
between fruit intake and folate intake. With the increase
of fruit intake, the folate level also increased. In the pre-
sent study, we used fruit folate values to estimate the
total folate intake. It may not reflect the truth and more
studies are needed to prove the association between
high dose folate and protective effects of prognosis after
esophagectomy.
Conclusions
Our research indicated that diet folate intake may have
benefits on the prognosis of ESCC after surgery. A ran-
domized clinical trial of folate supplementation among
post-esophagectomy patients is suggested to measure
the effect of supplement use of folate.
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